beta-casomorphin 5 has been researched along with naloxonazine in 1 studies
| Studies (beta-casomorphin 5) | Trials (beta-casomorphin 5) | Recent Studies (post-2010) (beta-casomorphin 5) | Studies (naloxonazine) | Trials (naloxonazine) | Recent Studies (post-2010) (naloxonazine) |
|---|---|---|---|---|---|
| 38 | 0 | 5 | 200 | 0 | 30 |
| Protein | Taxonomy | beta-casomorphin 5 (IC50) | naloxonazine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0072 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.136 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.085 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koseki, M; Matsumura, E; Sakaguchi, M; Wakamatsu, M | 1 |
1 other study(ies) available for beta-casomorphin 5 and naloxonazine
| Article | Year |
|---|---|
Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
Topics: Analgesics; Animals; Avoidance Learning; Cattle; Dose-Response Relationship, Drug; Endorphins; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Memory; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments; Receptors, Opioid, mu; Scopolamine | 2006 |